Paperpal Prime Logo

Wspolczesna Onkologia : Impact Factor & More

eISSN: 1897-4309pISSN: 1428-2526
JournalOpen Access

Key Metrics

CiteScore
2.8
SJR
Q3Oncology
SNIP
0.61
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Wspolczesna Onkologia

Wspolczesna Onkologia Journal Specifications

Overview
Publisher TERMEDIA PUBLISHING HOUSE LTD
Language English
Frequency Quarterly
Article Processing ChargesEUR 200
Publication Time24
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 24
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Wspolczesna Onkologia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Wspolczesna Onkologia

Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy
  • 1 Jan 2026
  • Contemporary Oncology
Best supportive care in patients with brain metastases: impact of the primary tumour type on survival.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Low-grade appendiceal mucinous neoplasm vs. high-grade appendiceal mucinous neoplasm: similarities, differences, and current management challenges
  • 1 Jan 2026
  • Contemporary Oncology
Fibroblast growth factor receptor 1 status discordance between primary breast tumours and lymph node metastases is associated with peripheral blood circulating tumour cell burden
  • 1 Jan 2026
  • Contemporary Oncology
Clinical guidelines for the management of cytostatic extravasation in children
  • 1 Jan 2026
  • Contemporary Oncology
Anticancer effects of fangchinoline in 4T1 breast cancer cells: in vitro and in silico analysis of TGF-\u03b21 and mTOR pathways
  • 1 Jan 2026
  • Contemporary Oncology
Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy
  • 1 Jan 2026
  • Contemporary Oncology
Best supportive care in patients with brain metastases: impact of the primary tumour type on survival.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Low-grade appendiceal mucinous neoplasm vs. high-grade appendiceal mucinous neoplasm: similarities, differences, and current management challenges
  • 1 Jan 2026
  • Contemporary Oncology
Fibroblast growth factor receptor 1 status discordance between primary breast tumours and lymph node metastases is associated with peripheral blood circulating tumour cell burden
  • 1 Jan 2026
  • Contemporary Oncology
Clinical guidelines for the management of cytostatic extravasation in children
  • 1 Jan 2026
  • Contemporary Oncology
Anticancer effects of fangchinoline in 4T1 breast cancer cells: in vitro and in silico analysis of TGF-\u03b21 and mTOR pathways
  • 1 Jan 2026
  • Contemporary Oncology

FAQs on Wspolczesna Onkologia